Results 261 to 270 of about 273,161 (350)

Restricted Expression of the Constant Region 1 of T‐Cell Receptor β by Flow Cytometry Facilitates Detection of T‐Cell Neoplasms With High Specificity but Moderate Predictive Value

open access: yesEuropean Journal of Haematology, Volume 116, Issue 3, Page 245-255, March 2026.
ABSTRACT Objectives To determine the diagnostic value of disclosing monotypic T‐cell populations by expression analysis of the constant region 1 of T‐cell receptor β (TRBC1) by flow cytometry, for the detection of T‐cell neoplasms, in a routine hematopathology practice setting.
Nilofar Rajabian   +4 more
wiley   +1 more source

Facts and Hopes: CAR T-Cell Therapy and Immune Contexture in Non-Hodgkin Lymphoma. [PDF]

open access: yesClin Cancer Res
Hijazi A   +6 more
europepmc   +1 more source

Primary and Secondary Grzybowski’s Generalized Eruptive Keratoacanthoma: A New Perspective on Management, Clinical Features, and Prognosis

open access: yesInternational Journal of Dermatology, Volume 65, Issue 3, Page 456-463, March 2026.
ABSTRACT Grzybowski's generalized eruptive keratoacanthoma (GEKA) is a rare variant of keratoacanthomas, characterized by hundreds to thousands of lesions, accompanied by pruritus, mucosal involvement, and comorbidities. Our aim was to analyze the clinical presentation, associated comorbidities, treatment strategies, and outcomes of GEKA.
Nicholas Florin Kormos   +6 more
wiley   +1 more source

Trends of Non-Hodgkin Lymphoma Incidence Among Adults in the United States From 2000 to 2020. [PDF]

open access: yesCancer Rep (Hoboken)
Aslani A   +5 more
europepmc   +1 more source

Developing and Testing Electronic Versions of the Advance QoL Tools for Collecting Self‐Reports of Quality of Life in Children and Adolescents With Advanced Cancer

open access: yesScandinavian Journal of Caring Sciences, Volume 40, Issue 1, March 2026.
ABSTRACT Introduction To provide appropriate interventions for young people with advanced cancer, self‐reported questionnaires assessing quality of life (QoL) are crucial. This study aims to develop and test electronic versions of two short self‐reported questionnaires (for children aged 8–12 and adolescents aged 13–18).
Lye‐Ann Robichaud   +8 more
wiley   +1 more source

Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 1, Page 51-57, March 2026.
ABSTRACT Mechlorethamine is commonly prescribed to dogs at 3 mg/m2. The minimal toxicity observed indicates that higher doses of mechlorethamine are likely tolerable. The primary objective of this study was to determine the maximally tolerated dose (MTD) of mechlorethamine in dogs with lymphoma.
Laura E. Chadsey   +2 more
wiley   +1 more source

A Comparative Study of Melanocytic Tumours: Linking Portuguese Dogs and Cats to Human Cases

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 1, Page 105-120, March 2026.
ABSTRACT Melanocytic tumours (MT) occur in both humans and companion animals, presenting an opportunity for comparative oncology research. Thus, this study provides a comprehensive epidemiological analysis comparing MT in Portuguese dogs, cats and humans. Data were obtained from the Portuguese National Cancer Registry (RON) (2011–2021) and Vet‐OncoNet (
Catarina Alves Pinto   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy